Search Results - "FACCHINETTI, F"

Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer by Ricordel, C, Friboulet, L, Facchinetti, F, Soria, J -C

“…Abstract Lung cancer represents the leading cause of cancer-related deaths worldwide. Despite great advances in its management with the recent emergence of…”
Get full text

Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis by Ferrazzi, E, Frigerio, L, Savasi, V, Vergani, P, Prefumo, F, Barresi, S, Bianchi, S, Ciriello, E, Facchinetti, F, Gervasi, MT, Iurlaro, E, Kustermann, A, Mangili, G, Mosca, F, Patanè, L, Spazzini, D, Spinillo, A, Trojano, G, Vignali, M, Villa, A, Zuccotti, GV, Parazzini, F, Cetin, I

“…Objective To report mode of delivery and immediate neonatal outcome in women infected with COVID‐19. Design Retrospective study. Setting Twelve hospitals in…”
Get full text

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy by Minari, R., Bordi, P., Del Re, M., Facchinetti, F., Mazzoni, F., Barbieri, F., Camerini, A., Comin, C.E., Gnetti, L., Azzoni, C., Nizzoli, R., Bortesi, B., Rofi, E., Petreni, P., Campanini, N., Rossi, G., Danesi, R., Tiseo, M.

“…•Liquid biopsy alone could underestimate coexistence of resistance mechanisms.•T790M plasma levels should be taken into account for clinical decisions.•Low…”
Get full text

Osimertinib in CNS-progressive EGFR-mutant lung cancer: do we need to detect T790M? by Facchinetti, F., Leonetti, A., Tiseo, M.

Get full text

A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups by Lindsay, C.R., Faugeroux, V., Michiels, S., Pailler, E., Facchinetti, F., Ou, D., Bluthgen, M.V., Pannet, C., Ngo-Camus, M., Bescher, G., Caramella, C., Billiot, F., Remon, J., Planchard, D., Soria, J.-C., Besse, B., Farace, F.

“…We report the first study examining the clinical, numerical and biological properties of circulating tumor cells according to molecular subtypes of…”
Get full text

Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials by Unfer, V., Carlomagno, G., Dante, G., Facchinetti, F.

“…Polycystic ovary syndrome (PCOS) affects 5%-10% of women in reproductive age, and it is the most common cause of infertility due to ovarian dysfunction and…”
Get full text

The establishment of the Experts Group on Inositol in Basic and Clinical Research (EGOI), a scientific association of the foremost experts on Inositol applications by Unfer, V, Facchinetti, F

Get more information

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer by Berchuck, J.E., Facchinetti, F., DiToro, D.F., Baiev, I., Majeed, U., Reyes, S., Chen, C., Zhang, K., Sharman, R., Uson Junior, P.L.S., Maurer, J., Shroff, R.T., Pritchard, C.C., Wu, M.-J., Catenacci, D.V.T., Javle, M., Friboulet, L., Hollebecque, A., Bardeesy, N., Zhu, A.X., Lennerz, J.K., Tan, B., Borad, M., Parikh, A.R., Kiedrowski, L.A., Kelley, R.K., Mody, K., Juric, D., Goyal, L.

“…Targeted therapies have transformed clinical management of advanced biliary tract cancer (BTC). Cell-free DNA (cfDNA) analysis is an attractive approach for…”
Get full text

Correction to: “Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer” by Ricordel, C., Friboulet, L., Facchinetti, F., Soria, J.-C.

Get full text

Targeting the MET gene for the treatment of non-small-cell lung cancer by Gelsomino, F, Facchinetti, F, Haspinger, E.R, Garassino, M.C, Trusolino, L, De Braud, F, Tiseo, M

“…Abstract Recently, a better understanding of the specific mechanisms of oncogene addiction has led to the development of antitumor strategies aimed at blocking…”
Get full text

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines by Passiglia, F., Pilotto, S., Facchinetti, F., Bertolaccini, L., Del Re, M., Ferrara, R., Franchina, T., Malapelle, U., Menis, J., Passaro, A., Ramella, S., Rossi, G., Trisolini, R., Novello, S.

“…The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung…”
Get full text

Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs by Santamaria, A., Alibrandi, A., Di Benedetto, A., Pintaudi, B., Corrado, F., Facchinetti, F., D’Anna, R.

“…Gestational diabetes mellitus is defined as carbohydrate intolerance that begins or is first recognized during pregnancy. Insulin sensitizing substances such…”
Get full text

Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer by Ricordel, C, Friboulet, L, Facchinetti, F, Soria, J -C

Get full text

Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy by Cortellini, A., Ricciuti, B., Facchinetti, F., Alessi, J.V.M., Venkatraman, D., Dall'Olio, F.G., Cravero, P., Vaz, V.R., Ottaviani, D., Majem, M., Piedra, A., Sullivan, I., Lee, K.A., Lamberti, G., Hussain, N., Clark, J., Bolina, A., Barba, A., Benitez, J.C., Gorría, T., Mezquita, L., Hoton, D., Aboubakar Nana, F., Besse, B., Awad, M.M., Pinato, D.J.

“…Prior antibiotic therapy (pATB) is known to impair efficacy of single-agent immune checkpoint inhibitors (ICIs), potentially through the induction of gut…”
Get full text

VP07.01: How adenomyosis changes throughout pregnancy: a retrospective study by Sileo, F.G., La Marca, A., Diamanti, M., Alboni, C., Facchinetti, F., Bertucci, E.

Get full text

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines by Passiglia, F., Bertolaccini, L., Del Re, M., Facchinetti, F., Ferrara, R., Franchina, T., Malapelle, U., Menis, J., Passaro, A., Pilotto, S., Ramella, S., Rossi, G., Trisolini, R., Novello, S.

“…The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the diagnosis and treatment of patients with early and…”
Get full text

Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients by Chen, J., Facchinetti, F., Braye, F., Yurchenko, A.A., Bigot, L., Ponce, S., Planchard, D., Gazzah, A., Nikolaev, S., Michiels, S., Vasseur, D., Lacroix, L., Tselikas, L., Nobre, C., Olaussen, K.A., Andre, F., Scoazec, J.Y., Barlesi, F., Soria, J.C., Loriot, Y., Besse, B., Friboulet, L.

“…The development of targeted agents, such as osimertinib for EGFR-mutated non-small-cell lung cancer (NSCLC), has drastically improved patient outcome, but…”
Get full text

Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype by Barbagallo, F., Pedrielli, G., Bosoni, D., Tiranini, L., Cucinella, L., Calogero, A. E., Facchinetti, F., Nappi, R. E.

“…Purpose To study sexual function and distress in women with functional hypothalamic amenorrhea (FHA) compared to women with FHA and an underlying polycystic…”
Get full text

EP05.07: Fetal MRI in fetuses with central nervous system anomalies: a single institution experience by Sileo, F.G., Giuliani, G., Ballarini, M., Contu, G., Lugli, L., Cavalleri, F., Todeschini, A., Genovese, M., Facchinetti, F., Bertucci, E.

Get full text

Preterm Labor and Birth Management: Recommendations from the European Association of Perinatal Medicine by Di Renzo, G. C., Cabero Roura, L., Facchinetti, F., Helmer, H., Hubinont, C., Jacobsson, B., Jørgensen, J. S., Lamont, R. F., Mikhailov, A., Papantoniou, N., Radzinsky, V., Shennan, A., Ville, Y., Wielgos, M., Visser, G. H. A.

Get full text